Connect to other sites within the UBM Medica Network
Preventive options are scarce. What about cognitive behavioral therapy?
7 Modifiable Risk Factors for Atrial Fibrillation
Find data here on obesity, exercise, and OSA, plus 4 more factors that increase the risk for AF and other CV disease.
Risk of Atrial Fibrillation is Associated with Gout
A large population-based study found more patients already had atrial fibrillation at gout diagnosis compared with controls.
ROCKET-AF Trial Results Under Fire
Concern that equipment error may have led to higher doses of warfarin than necessary call the huge trial's findings into question.
To Bridge or Not To Bridge? Is it the Wrong Question?
Results of two recent studies suggest that perioperative "bridge" anticoagulation may do more harm than good in some patients.
Anticoagulant Use Among Afib Patients Wanes Over Time
Study results presented at the 2015 AHA meeting reinforce, once again, the critical role of persistent patient education on treatment adherence.
Risk of Atrial Fibrillation Increased in HFpEF
Data from a recent study suggest that paroxysmal AF may be underdiagnosed in patients with heart failure and preserved ejection fraction.
At Long Last, an Antidote for a NOAC!
The anticoagulant reversal agent idarucizumab was approved as the antidote to dabigatran via the FDA's accelerated approval program.
Atrial Fibrillation Video: Symptoms, Cardioversion Strategies
A nurse describes his own bout with atrial fibrillation—the symptoms and his attempts to cardiovert to normal rhythm—from his hospital bed.
Secondary AF: Risk of Recurrence Found in Framingham
Is new-onset AF linked to an acute precipitant less likely to recur than spontaneous AF? Is it any less dangerous? A new study finds answers in Framingham data.
Obesity and AF: A Dose-dependent Relationship
A recent literature analysis found a 10% to 29% excess risk for AF conferred by incremental increases in BMI. The study in 9 slides, here.
3 Myths About New Oral Anticoagulants Debunked for Primary Care Physicians
No monitoring necessary; don't use them before electrical cardioversion; and count them out for periprocedural use during AF ablation. Really?
Just Say No to Anticoagulation for These Patients With Atrial Fibrillation
Guidelines say “no” to anticoagulation for young, otherwise healthy persons with atrial fibrillation. New research finds that clinical practice looks quite different.
By clicking Accept, you agree to become a member of the UBM Medica Community.